{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:45:17Z","timestamp":1751053517164},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf00877956","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T17:02:55Z","timestamp":1111597375000},"page":"29-44","source":"Crossref","is-referenced-by-count":17,"title":["Renal excretory responses to single and repeated administration of diuretics in healthy subjects: Clinical connotations"],"prefix":"10.1007","volume":"7","author":[{"given":"Ariel J.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William P.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"332","volume-title":"Diuretics II: Chemistry, pharmacology, and clinical applications","author":"AJ Reyes","year":"1987","unstructured":"Reyes AJ. Diuretics in heart failure. In: Puschett JB, Greenberg A, eds.Diuretics II: Chemistry, pharmacology, and clinical applications. New York: Elsevier, 1987:332?344."},{"key":"CR2","first-page":"93","volume":"9","author":"AJ Reyes","year":"1987","unstructured":"Reyes AJ. Interactions between magnesium and drugs in congestive heart failure.Magnesium-Bull 1987;9:93?109.","journal-title":"Magnesium-Bull"},{"issue":"3","key":"CR3","first-page":"167","volume":"6","author":"AJ Reyes","year":"1988","unstructured":"Reyes AJ. Therapy with diuretics in congestive heart failure.Prog Pharmacol 1988;6(3):167?192.","journal-title":"Prog Pharmacol"},{"issue":"Suppl 3","key":"CR4","first-page":"33","volume":"41","author":"AJ Reyes","year":"1991","unstructured":"Reyes AJ. Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects.Drugs 1991;41(Suppl 3):33?59.","journal-title":"Drugs"},{"issue":"I","key":"CR5","first-page":"151","volume":"38","author":"R Greger","year":"1988","unstructured":"Greger R. Inhibition of active NaCl reabsorption in the thick ascending limb of the loop of Henle by torasemide.Arzneim-Forsch\/Drug Res 1988;38(I):151?152.","journal-title":"Arzneim-Forsch\/Drug Res"},{"issue":"II","key":"CR6","first-page":"1527","volume":"35","author":"A Ghys","year":"1985","unstructured":"Ghys A, Denef J, Delarge J, et al. Renal effects of the high ceiling diuretic torasemide in rats and dogs.Arzneim-Forsch\/Drug Res 1985;35(II):1527?1531.","journal-title":"Arzneim-Forsch\/Drug Res"},{"key":"CR7","first-page":"219","volume":"9","author":"AJ Reyes","year":"1992","unstructured":"Reyes AJ, Leary WP, van der Byl K. Renal excretory responses to single and repeated administration of loop and of early distal tubular diuretics at various doses in healthy man.Prog Pharmacol Clin Pharmacol 1992;9:219?262.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"CR8","first-page":"131","volume":"9","author":"AJ Reyes","year":"1992","unstructured":"Reyes AJ, Leary WP. Clinicopharmacological definition of the potency of diuretics and reclassification of diuretics by their clinicopharmacological potency.Prog Pharmacol Clin Pharmacol 1992;9:131?146.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"3","key":"CR9","first-page":"83","volume":"6","author":"AJ Reyes","year":"1988","unstructured":"Reyes AJ, Leary WP, van der Byl K, et al. Renal excretory pharmacodynamics of diuretics in man: Comparison between furosemide, hydrochlorothiazide and torasemide.Prog Pharmacol 1988;6(3):83?151.","journal-title":"Prog Pharmacol"},{"issue":"1","key":"CR10","first-page":"47","volume":"8","author":"AJ Reyes","year":"1990","unstructured":"Reyes AJ, Leary WP, van der Byl K. Excretion of urinary fluid and solutes after single doses of furosemide and hydrochlorothiazide and of four single doses of the diuretic torasemide in healthy subjects.Prog Pharmacol Clin Pharmacol 1990;8(1):47?71.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"Suppl 1","key":"CR11","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/00005344-198507001-00012","volume":"7","author":"WP Leary","year":"1985","unstructured":"Leary WP, Reyes AJ, van der Byl K, et al. Effects of captopril, hydrochlorothiazide and their combination on timed urinary excretions of water and solutes.J Cardiovasc Pharmacol 1985;7(Suppl 1):S56-S62.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/030006059001800207","volume":"18","author":"WP Leary","year":"1990","unstructured":"Leary WP, Reyes AJ, Wynne RD, et al. Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects.J Int Med Res 1990;18:120?141.","journal-title":"J Int Med Res"},{"key":"CR13","first-page":"72","volume-title":"Diuretics III: Chemistry, pharmacology, and clinical applications","author":"AJ Reyes","year":"1990","unstructured":"Reyes AJ, Leary WP, van der Byl K. The UY Mathematical Model of urinary fluid and solute continuous flows. In: Puschett JB, Greenberg A, eds.Diuretics III: Chemistry, pharmacology, and clinical applications. New York: Elsevier, 1990:72?74."},{"key":"CR14","first-page":"69","volume-title":"Diuretics III: Chemistry, pharmacology, and clinical applications","author":"AJ Reyes","year":"1990","unstructured":"Reyes AJ, Leary WP, van der Byl K. Instantaneous renal clearance derived by the UY Mathematical Model. In: Puschett JB, Greenberg A, eds.Diuretics III: Chemistry, pharmacology, and clinical applications. New York: Elsevier, 1990:69?71."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ki.1983.22","volume":"23","author":"P Weidmann","year":"1983","unstructured":"Weidmann P, Beretta-Piccoli C, Meier A, et al. Antihypertensive mechanism of diuretic treatment with chlorthalidone. Complementary roles of sympathetic axis and sodium.Kidney Int 1983;23:320?326.","journal-title":"Kidney Int"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0026-0495(83)90229-9","volume":"32","author":"GT Griffing","year":"1983","unstructured":"Griffing GT, Sindler BH, Aurecchia SA, et al. The effects of hydrochlorothiazide on the renin-aldosterone system.Metabolism 1983;32:197?201.","journal-title":"Metabolism"},{"key":"CR17","first-page":"325","volume-title":"The regulation of potassium balance","author":"CS Wilcox","year":"1989","unstructured":"Wilcox CS. Diuretics and potassium. In: Seldin DW, Giebisch G, eds.The regulation of potassium balance. New York: Raven Press, 1989:325?345."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00609181","volume":"36","author":"P Lijnen","year":"1989","unstructured":"Lijnen P, Hespel P, Fagard R, et al. Plasma atrial natriuretic peptide and the renin-aldosterone system during long-term administration of the diuretic xipamide in man.Eur J Clin Pharmacol 1989;36:111?117.","journal-title":"Eur J Clin Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"S477","DOI":"10.1097\/00005344-198400063-00004","volume":"6","author":"JR Sowers","year":"1984","unstructured":"Sowers JR. The impact of diuretics on potassium and glucose.J Cardiovasc Pharmacol 1984;6:S477-S482.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ki.1985.229","volume":"28","author":"RL Tannen","year":"1985","unstructured":"Tannen RL. Diuretic-induced hypokalaemia.Kidney Int 1985;28:988?1000.","journal-title":"Kidney Int"},{"issue":"1","key":"CR21","first-page":"45","volume":"6","author":"FG McMahon","year":"1985","unstructured":"McMahon FG. The role of potassium in hypertension.Prog Pharmacol 1985;6(1):45?50.","journal-title":"Prog Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.pa.26.040186.001453","volume":"26","author":"H Vel\u00e1zquez","year":"1986","unstructured":"Vel\u00e1zquez H, Wright FS. Control by drugs of renal potassium handling.Annu Rev Pharmacol 1986;26:293?309.","journal-title":"Annu Rev Pharmacol"},{"key":"CR23","first-page":"184","volume":"10","author":"H Vel\u00e1zquez","year":"1987","unstructured":"Vel\u00e1zquez H. Thiazide diuretics.Renal Physiol 1987;10:184?197.","journal-title":"Renal Physiol"},{"key":"CR24","first-page":"F811","volume":"255","author":"DB Young","year":"1988","unstructured":"Young DB. Quantitative analysis of aldosterone's role in potassium regulation.Am J Physiol 1988;255:F811-F822.","journal-title":"Am J Physiol"},{"key":"CR25","first-page":"1323","volume-title":"The kidney: Physiology and pathophysiology","author":"ZS Agus","year":"1985","unstructured":"Agus ZS, Goldfarb S. Renal regulation of calcium balance. In: Seldin DW, Giebisch G, eds.The kidney: Physiology and pathophysiology. New York: Raven Press, 1985:1323?1335."},{"key":"CR26","first-page":"169","volume-title":"Diuretics: Chemistry, pharmacology, and clinical applications","author":"L Costanzo","year":"1984","unstructured":"Costanzo L. Effects of diuretics on the distal convoluted tubular transport of calcium. In: Puschett JB, Greenberg A, eds.Diuretics: Chemistry, pharmacology, and clinical applications. New York: Elsevier, 1984:169?173."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pa.26.040186.000533","volume":"26","author":"CT Stier","year":"1986","unstructured":"Stier CT, Itskovitz HD. Renal calcium metabolism and diuretics.Annu Rev Pharmacol Toxicol 1986;26:101?116.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/978-1-4613-2067-8_129","volume-title":"Diuretics: Basic, pharmacological, and clinical aspects","author":"AJ Reyes","year":"1987","unstructured":"Reyes AJ, Leary WP. Natriuretic potency of various diuretics. In: Andreucci V, Dal Canton A, eds.Diuretics: Basic, pharmacological, and clinical aspects. Boston: Martinus Nijhoff, 1987:506?508."},{"issue":"3","key":"CR29","first-page":"153","volume":"6","author":"WP Leary","year":"1988","unstructured":"Leary WP, Reyes AJ. Renal excretory actions of diuretics in man: Correction of various current errors and redefinition of basic concepts.Prog Pharmacol 1988;6(3):153?166.","journal-title":"Prog Pharmacol"},{"key":"CR30","first-page":"447","volume":"233","author":"MM Hammarlund","year":"1985","unstructured":"Hammarlund MM, Odlind B, Paalzow K. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.J Pharmacol Exp Ther 1985;233:447?453.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00365599.1988.11690399","volume":"22","author":"PA Sj\u00f6str\u00f6m","year":"1988","unstructured":"Sj\u00f6str\u00f6m PA, Odlind BG, Beermann BA, et al. On the mechanism of acute tolerance to furosemide diuresis.Scand J Urol Nephrol 1988;22:133?140.","journal-title":"Scand J Urol Nephrol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00003088-198005030-00003","volume":"5","author":"B Beermann","year":"1980","unstructured":"Beermann B, Groschinsky-Grind M. Clinical pharmacokinetics of diuretics.Clin Pharmacokin 1980;5:221?245.","journal-title":"Clin Pharmacokin"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2165\/00003088-198713040-00003","volume":"13","author":"B Beermann","year":"1987","unstructured":"Beermann B, Grind M. Clinical pharmacokinetics of some newer diuretics.Clin Pharmacokin 1987;13:254?256.","journal-title":"Clin Pharmacokin"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bdd.2510070602","volume":"7","author":"PG Welling","year":"1986","unstructured":"Welling PG. Pharmacokinetics of the thiazide diuretics.Biopharm Drug Disp 1986;7:501?535.","journal-title":"Biopharm Drug Disp"},{"issue":"I","key":"CR35","first-page":"200","volume":"38","author":"K Kl\u00fctsch","year":"1988","unstructured":"Kl\u00fctsch K, Grosswendt J, Haecker W. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.Arzneim-Forsch\/Drug Res 1988;38(I):200?204.","journal-title":"Arzneim-Forsch\/Drug Res"},{"issue":"I","key":"CR36","first-page":"205","volume":"38","author":"G Mourad","year":"1988","unstructured":"Mourad G, Haecker W, Mion C. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.Arzneim-Forsch\/Drug Res 1988;38(I):205?208.","journal-title":"Arzneim-Forsch\/Drug Res"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00365598709180292","volume":"21","author":"P Sj\u00f6str\u00f6m","year":"1987","unstructured":"Sj\u00f6str\u00f6m P, Beermann B, Odlind B. Pharmacokinetic-pharmacodynamic relationship of piretanide in healthy and uremic subjects.Scand J Urol Nephrol 1987;21:55?64.","journal-title":"Scand J Urol Nephrol"},{"issue":"Suppl","key":"CR38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00541465","volume":"31","author":"AJ Scheen","year":"1986","unstructured":"Scheen AJ, Vancrombreucq JC, Delarge J, et al. Diuretic activity of torasemide and furosemide in chronic heart failure. A comparative double-blind cross-over study.Eur J Clin Pharmacol 1986;31(Suppl):35?42.","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl","key":"CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00541464","volume":"31","author":"J Broekhuysen","year":"1986","unstructured":"Broekhuysen J, Deger F, Douchamps J, et al. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.Eur J Clin Pharmacol 1986;31(Suppl):29?34.","journal-title":"Eur J Clin Pharmacol"},{"key":"CR40","first-page":"364","volume-title":"Diuretics: Chemistry, pharmacology, and clinical applications","author":"RC Hamdy","year":"1984","unstructured":"Hamdy RC, Vinson M, Robbins AD, et al. 24 hour urinary electrolyte profile following frusemide, amiloride and a combination of these drugs Frumil?. In: Puschett JB, Greenberg A, eds.Diuretics: Chemistry, pharmacology, and clinical applications. New York: Elsevier, 1984:364?366."},{"key":"CR41","first-page":"450","volume":"102","author":"CS Wilcox","year":"1983","unstructured":"Wilcox CS, Mitch WE, Kelly RA, et al. Response of the kidney to furosemide: Effects of salt intake and renal compensation.J Lab Med 1983;102:450?458.","journal-title":"J Lab Med"},{"issue":"1","key":"CR42","first-page":"15","volume":"8","author":"WH Barr","year":"1990","unstructured":"Barr WH, Smith H, Karnes HT, et al. Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers.Prog Pharmacol Clin Pharmacol 1990;8(1):15?28.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","volume":"36","author":"NR Loon","year":"1989","unstructured":"Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy.Kidney Int 1989;36:682?689.","journal-title":"Kidney Int"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ki.1983.149","volume":"24","author":"RA Kelly","year":"1983","unstructured":"Kelly RA, Wilcox CS, Mitch WE, et al. Response of the kidney to furosemide: Effect of captopril on sodium balance.Kidney Int 1983;24:233?239.","journal-title":"Kidney Int"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.1987.20","volume":"31","author":"CS Wilcox","year":"1987","unstructured":"Wilcox CS, Guzman NJ, Mitch WE, et al. Na+, K+, and BP homeostasis in man during furosemide: Effect of prazosin and captopril.Kidney Int 1987;31:135?141.","journal-title":"Kidney Int"},{"key":"CR46","first-page":"19","volume":"A9","author":"R Nicolantonio Di","year":"1987","unstructured":"Di Nicolantonio R, Morgan TO. Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide.Clin Exp Hypertens 1987;A9:19?32.","journal-title":"Clin Exp Hypertens"},{"key":"CR47","first-page":"309","volume":"22","author":"G B\u00f6nner","year":"1987","unstructured":"B\u00f6nner G, Gentges A, Wambach G, et al. Diminution by captopril of the diuretic, natriuretic and kallikrein stimulating action of furosemide by reduction in its renal secretion.Agents Actions 1987;22:309?319.","journal-title":"Agents Actions"},{"key":"CR48","first-page":"F374","volume":"248","author":"B Kaissling","year":"1985","unstructured":"Kaissling B, Bachmann S, Kriz W. Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment.Am J Physiol 1985;248:F374-F381.","journal-title":"Am J Physiol"},{"key":"CR49","first-page":"2717","volume":"44","author":"BA Stanton","year":"1985","unstructured":"Stanton BA. Role of adrenal hormones in regulating distal nephron structure and ion transport.Fed Proc 1985;44:2717?2722.","journal-title":"Fed Proc"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/00365598809180807","volume":"22","author":"PA Sj\u00f6str\u00f6m","year":"1988","unstructured":"Sj\u00f6str\u00f6m PA, Beermann BA, Odlind BG. Delayed tolerance to furosemide diuresis.Scand J Urol Nephrol 1988;22:317?325.","journal-title":"Scand J Urol Nephrol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1152\/physrev.1985.65.3.760","volume":"65","author":"R Greger","year":"1985","unstructured":"Greger R. Ion transport mechanisms in the thick ascending limb of Henle's loop of mammalian nephron.Physiol Rev 1985;65:760?797.","journal-title":"Physiol Rev"},{"key":"CR52","first-page":"174","volume":"10","author":"R Greger","year":"1988","unstructured":"Greger R, Wangemann P. Loop diuretics.Renal Physiol 1988;10:174?183.","journal-title":"Renal Physiol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajpcell.1982.243.1.C1","volume":"243","author":"FS Wright","year":"1982","unstructured":"Wright FS. Flow-dependent transport processes: Filtration, absorption, secretion.Am J Physiol 1982;243:F1-F11.","journal-title":"Am J Physiol"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/BF01738140","volume":"63","author":"G Giebisch","year":"1985","unstructured":"Giebisch G. Hormonal control of distal nephron function.Klin Wochen 1985;63:877?885.","journal-title":"Klin Wochen"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/cs0670195","volume":"67","author":"CS Wilcox","year":"1984","unstructured":"Wilcox CS, Mitch WE, Kelly RA, et al. Factors affecting potassium balance during furosemide administration.Clin Sci 1984;67:195?203.","journal-title":"Clin Sci"},{"key":"CR56","first-page":"382","volume":"20","author":"M Lesne","year":"1982","unstructured":"Lesne M, Clerckx-Braun F, Duhoux P, et al. Pharmacokinetic study of torasemide in humans: An overview of its diuretic effect.Int J Clin Pharmacol Ther Toxicol 1982;20:382?387.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"Suppl","key":"CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00541460","volume":"31","author":"Y Ambroes","year":"1986","unstructured":"Ambroes Y, Ronflette I, Dodion L. Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.Eur J Clin Pharmacol 1986;31(Suppl):1?7.","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl","key":"CR58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00541462","volume":"31","author":"R Cuvelier","year":"1986","unstructured":"Cuvelier R, Pellegrini P, Lesne M, et al. Site of action of torasemide in man.Eur J Clin Pharmacol 1986;31(Suppl):15?19.","journal-title":"Eur J Clin Pharmacol"},{"issue":"I","key":"CR59","first-page":"164","volume":"38","author":"G Neugebauer","year":"1988","unstructured":"Neugebauer G, Besenfelder E, von M\u00f6llendorf E. Pharmacokinetics and metabolism of torasemide in man.Arzneim-Forsch\/Drug Res 1988;38(I):164?166.","journal-title":"Arzneim-Forsch\/Drug Res"},{"issue":"1","key":"CR60","first-page":"29","volume":"8","author":"WH Barr","year":"1990","unstructured":"Barr WH, Smith HL, Karnes HT, et al. Torasemide dose-proportionality of pharmacokinetics and pharmacodynamics.Prog Pharmacol Clin Pharmacol 1990;8(1):29?37.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00561397","volume":"18","author":"J Elmgreen","year":"1980","unstructured":"Elmgreen J, Tougaard L, Leth A, et al. Elevated serum parathyroid hormone concentration during treatment with high ceiling diuretics.Eur J Clin Pharmacol 1980;18:363?364.","journal-title":"Eur J Clin Pharmacol"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000183290","volume":"38","author":"T Fujita","year":"1984","unstructured":"Fujita T, Chan CM, Bartter FC. Effects of oral furosemide and salt loading on parathyroid function in normal subjects.Nephron 1984;38:109?114.","journal-title":"Nephron"},{"key":"CR63","first-page":"265","volume":"2","author":"AG Dupont","year":"1988","unstructured":"Dupont AG, Schoors D, Six RO, et al. Antihypertensive efficacy of low dose torasemide in essential hypertension: A placebo-controlled study.J Human Hypertens 1988;2:265?268.","journal-title":"J Human Hypertens"},{"issue":"I","key":"CR64","first-page":"190","volume":"38","author":"N Spannbrucker","year":"1988","unstructured":"Spannbrucker N, Achhammer I, Metz P, et al. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.Arzneim-Forsch\/Drug Res 1988;38(I):190?193.","journal-title":"Arzneim-Forsch\/Drug Res"},{"issue":"I","key":"CR65","first-page":"194","volume":"38","author":"AJ Reyes","year":"1988","unstructured":"Reyes AJ. Formal comparison of the antihypertensive effects of torasemide and other diuretics by the Montevideo Mathematical Model.Arzneim-Forsch\/Drug Res 1988;38(I):194?199.","journal-title":"Arzneim-Forsch\/Drug Res"},{"issue":"1","key":"CR66","first-page":"169","volume":"8","author":"P Baumgart","year":"1990","unstructured":"Baumgart P, Walger P, v. Eiff M, et al. Long-term efficacy and tolerance of torasemide in hypertension.Prog Pharmacol Clin Pharmacol 1990;8(1):169?181.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"1","key":"CR67","first-page":"183","volume":"8","author":"AJ Reyes","year":"1990","unstructured":"Reyes AJ, Chiesa PD, Santucci MR, et al. Hydrochlorothiazide versus a non-diuretic dose of torasemide as once-daily antihypertensive monopharmacotherapy in elderly patients. A randomized and double-blind study.Prog Pharmacol Clin Pharmacol 1990;8(1):183?209.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"1","key":"CR68","first-page":"211","volume":"8","author":"I Achhammer","year":"1990","unstructured":"Achhammer I, Eberhard R. Comparison of serum potassium levels during long-term treatment of hypertensive patients with 2.5 mg torasemide\/day or 50 mg triamterene\/25 mg hydrochlorothiazide\/day.Prog Pharmacol Clin Pharmacol 1990;8(1):211?220.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00609982","volume":"13","author":"B Beermann","year":"1978","unstructured":"Beermann B, Groschinsky-Grind M. Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug.Eur J Clin Pharmacol 1978;13:195?201.","journal-title":"Eur J Clin Pharmacol"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/cpt1978242192","volume":"24","author":"BJ Materson","year":"1978","unstructured":"Materson BJ, Oster JR, Michael UF, et al. Dose response to chlorthalidone in patients with mild hypertension.Clin Pharmacol Ther 1978;24:192?198.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"CR71","first-page":"193","volume":"6","author":"AJ Reyes","year":"1988","unstructured":"Reyes AJ, Leary WP, Alcocer L. The antihypertensive effect of diuretics: Overview and formal evaluation by the Montevideo Mathematical Model.Prog Pharmacol 1988;6(3):193?243.","journal-title":"Prog Pharmacol"},{"key":"CR72","first-page":"415","volume-title":"Magnesium in health and disease","author":"AJ Reyes","year":"1989","unstructured":"Reyes AJ. Mechanisms and extent of the decrease in magnesiuresis induced by antikaliuretic diuretics in man. In: Itokawa Y, Durlach J, eds.Magnesium in health and disease. London Paris: John Libbey, 1989:415?422."},{"issue":"1","key":"CR73","first-page":"51","volume":"6","author":"AJ Reyes","year":"1985","unstructured":"Reyes AJ. Deleterious effects of antihypertensive treatment on magnesium turnover.Prog Pharmacol 1985;6(1):51?87.","journal-title":"Prog Pharmacol"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02125830","volume":"1","author":"WP Leary","year":"1987","unstructured":"Leary WP, Reyes AJ. Angiotensin-I converting enzyme inhibitors and the renal excretion of urate.Cardiovasc Drugs Ther 1987;1:28?39.","journal-title":"Cardiovasc Drugs Ther"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2165\/00003495-198529020-00003","volume":"29","author":"AF Lant","year":"1985","unstructured":"Lant AF. Diuretics. Clinical pharmacology and therapeutic use (part II).Drugs 1985;29:162?168.","journal-title":"Drugs"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4613-2067-8_55","volume-title":"Diuretics: Basic, pharmacological, and clinical aspects","author":"JL Rodicio","year":"1987","unstructured":"Rodicio JL, Alcazar JM, Nieto J, et al. Metabolic effects of long-term diuretic treatment. In: Andreucci V, Dal Canton A, eds.Diuretics: Basic, pharmacological, and clinical aspects. Boston: Martinus Nijhoff, 1987:231?236."},{"key":"CR77","first-page":"109","volume-title":"Diuretics: Chemistry, pharmacology, and clinical applications","author":"P Wicker","year":"1984","unstructured":"Wicker P, Clementy J. Comparison of the effects of muzolimine and a fixed combination of hydrochlorothiazide and amiloride in mildly to moderately hypertensive patients. In: Puschett JB, Greenberg A, eds.Diuretics: Chemistry, pharmacology, and clinical applications. New York: Elsevier, 1984:109?111."},{"issue":"Suppl 2","key":"CR78","first-page":"66","volume":"74","author":"R Kirsten","year":"1985","unstructured":"Kirsten R, Molg KH, Tzonev I, et al. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.Z Kardiol 1985;74(Suppl 2):66?72.","journal-title":"Z Kardiol"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4613-2067-8_65","volume-title":"Diuretics: Basic, pharmacological, and clinical aspects","author":"V Canonico","year":"1987","unstructured":"Canonico V, Morgano G, Petretta M, et al. Muzolimine versus captopril in low and mild hypertension. In: Andreucci V, Dal Canton A, eds.Diuretics: Basic, pharmacological, and clinical aspects. Boston: Martinus Nijhoff, 1987:283?285."},{"key":"CR80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4613-2067-8_76","volume-title":"Diuretics: Basic, pharmacological, and clinical aspects","author":"M Carnovali","year":"1987","unstructured":"Carnovali M, Borguino C, Crespi E, et al. Efficacy and tolerability of muzolimine in the long-term treatment of essential hypertension. In: Andreucci V, Dal Canton A, eds.Diuretics: Basic, pharmacological, and clinical aspects. Boston: Martinus Nijhoff, 1987:317?319."},{"key":"CR81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4613-2067-8_78","volume-title":"Diuretics: Basic, pharmacological, and clinical aspects","author":"V Ortalda","year":"1987","unstructured":"Ortalda V, Valvo E, Fabris A, et al. Long-term therapy with muzolimine in patients with mild to moderate essential hypertension. In: Andreucci V, Dal Canton A, eds.Diuretics: Basic, pharmacological, and clinical aspects. Boston: Martinus Nijhoff, 1987:323?325."},{"issue":"Suppl 2","key":"CR82","first-page":"56","volume":"74","author":"M Cocchieri","year":"1985","unstructured":"Cocchieri M, Chiuini E, Fortunati F, et al. Efficacy of two different doses of muzolimine in the treatment of mild hypertension.Z Kardiol 1985;74(Suppl 2):56?59.","journal-title":"Z Kardiol"},{"issue":"Suppl 3","key":"CR83","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00003495-199100413-00009","volume":"41","author":"I Achhammer","year":"1991","unstructured":"Achhammer I, Metz P. Low dose loop diuretics in essential hypertension: Experience with torasemide.Drugs 1991;41(Suppl 3):80?91.","journal-title":"Drugs"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1016\/0002-9149(85)91199-3","volume":"56","author":"WW Parmley","year":"1985","unstructured":"Parmley WW. Pathophysiology of congestive heart failure.Am J Cardiol 1985;56:7A-11A.","journal-title":"Am J Cardiol"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/0002-9149(85)91188-9","volume":"56","author":"KT Weber","year":"1985","unstructured":"Weber KT, Janicki JS, Maskin CS. Pathophysiology of cardiac failure.Am J Cardiol 1985;56:3B-7B.","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"CR86","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00005344-198600081-00009","volume":"8","author":"WJ Remme","year":"1986","unstructured":"Remme WJ. Congestive heart failure?pathophysiology and medical treatment.J Cardiovasc Pharmacol 1986;8(Suppl 1):S36-S52.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR87","first-page":"941","volume":"3","author":"P Harris","year":"1989","unstructured":"Harris P. Congestive cardiac failure: The syndrome of volume expansion.Cardiovasc Drug Ther 1989;3:941?946.","journal-title":"Cardiovasc Drug Ther"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/BF01858111","volume":"3","author":"R Ferrari","year":"1989","unstructured":"Ferrari R, Anand I. Neurohumoral changes in untreated heart failure.Cardiovasc Drugs Ther 1989;3:979?986.","journal-title":"Cardiovasc Drugs Ther"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00005344-198611000-00003","volume":"8","author":"AJG Riegger","year":"1986","unstructured":"Riegger AJG, Kromer EP, Kochsiek K. Human atrial natriuretic peptide: Plasma levels, hemodynamic, hormonal and renal effects in patients with severe congestive heart failure.J Cardiovasc Pharmacol 1986;8:1107?1112.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/clpt.1980.148","volume":"28","author":"DC Brater","year":"1980","unstructured":"Brater DC, Chennavasin P, Seiwell R. Furosemide in patients with heart failure: Shift in dose-response curves.Clin Pharmacol Ther 1980;28:182?186.","journal-title":"Clin Pharmacol Ther"},{"issue":"II","key":"CR91","first-page":"256","volume":"25","author":"G Voltz","year":"1975","unstructured":"Voltz G. Behaviour of electrolyte and acid-base balance during treatment with 4-chloro-5-sulfamoyl-2?,6?-salicyloxylidide (Xipamid INN) with particular regard to potassium balance.Arzneim-Forsch\/Drug Res 1975;25(II):256?258.","journal-title":"Arzneim-Forsch\/Drug Res"},{"issue":"Suppl 1","key":"CR92","first-page":"S85","volume":"19","author":"G Ziakas","year":"1983","unstructured":"Ziakas G, Zioutas G, Arvanitidis T, et al. Muzolimine in patients with cardiac edema: A comparison with furosemide in a repeated-dose, single-blind study.Clin Nephrol 1983;19(Suppl 1):S85-S91.","journal-title":"Clin Nephrol"},{"issue":"1","key":"CR93","first-page":"121","volume":"8","author":"M Stauch","year":"1990","unstructured":"Stauch M, Stiehl L. Controlled, double-blind clinical trial of the efficacy and tolerance of torasemide in comparison with furosemide in patients with congestive heart failure?a multicenter study.Prog Pharmacol Clin Pharmacol 1990;8(1):121?126.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"1","key":"CR94","first-page":"127","volume":"8","author":"I Achhammer","year":"1990","unstructured":"Achhammer I. Long term efficacy and tolerance of torasemide in congestive heart failure.Prog Pharmacol Clin Pharmacol 1990;8(1):127?136.","journal-title":"Prog Pharmacol Clin Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877956.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00877956\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T08:57:29Z","timestamp":1556528249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00877956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":94,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF00877956"],"URL":"https:\/\/doi.org\/10.1007\/bf00877956","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}